The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124305453 12430545 3 F 2016 20160705 20160602 20160712 EXP FR-ASTRAZENECA-2016SE56632 ASTRAZENECA 77.00 YR M Y 70.00000 KG 20160713 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124305453 12430545 1 PS BRILIQUE TICAGRELOR 1 Oral 22433 2 DF TABLET QD
124305453 12430545 2 SS BRILIQUE TICAGRELOR 1 Oral 22433 2 DF TABLET QD
124305453 12430545 3 SS BRILIQUE TICAGRELOR 1 Oral 22433 2 DF TABLET QD
124305453 12430545 4 SS BRILIQUE TICAGRELOR 1 Oral 22433 2 DF TABLET QD
124305453 12430545 5 SS BRILIQUE TICAGRELOR 1 Oral 22433 90 MG TABLET BID
124305453 12430545 6 SS BRILIQUE TICAGRELOR 1 Oral 22433 90 MG TABLET BID
124305453 12430545 7 SS BISOPROLOL BISOPROLOL 1 Unknown 10.0MG UNKNOWN 0 10 MG
124305453 12430545 8 SS BISOPROLOL BISOPROLOL 1 Unknown 5.0MG UNKNOWN 0 5 MG QD
124305453 12430545 9 C LASILIX FUROSEMIDE 1 0 40 MG QD
124305453 12430545 10 C KARDEGIC ASPIRIN LYSINE 1 75 MG AT NOON 0
124305453 12430545 11 C INSPRA EPLERENONE 1 0 25 MG QD
124305453 12430545 12 C ATORVASTATINE ATORVASTATIN 1 0 80 MG QD
124305453 12430545 13 C PERINDOPRIL PERINDOPRIL 1 0 2 MG QD
124305453 12430545 14 C LERCANIDIPINE LERCANIDIPINE 1 10.0MG UNKNOWN 0 10 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124305453 12430545 1 Myocardial infarction
124305453 12430545 2 Embolism
124305453 12430545 3 Myocardial infarction
124305453 12430545 4 Embolism
124305453 12430545 5 Myocardial infarction
124305453 12430545 6 Embolism
124305453 12430545 7 Myocardial infarction
124305453 12430545 8 Myocardial infarction
124305453 12430545 9 Myocardial infarction
124305453 12430545 10 Myocardial infarction
124305453 12430545 11 Myocardial infarction
124305453 12430545 12 Myocardial infarction
124305453 12430545 13 Myocardial infarction
124305453 12430545 14 Hypertension

Outcome of event

Event ID CASEID OUTC COD
124305453 12430545 LT
124305453 12430545 HO
124305453 12430545 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124305453 12430545 Blood pressure decreased
124305453 12430545 Bradycardia
124305453 12430545 Drug dose omission
124305453 12430545 Dyspnoea
124305453 12430545 Pulmonary oedema
124305453 12430545 Vascular stent thrombosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124305453 12430545 1 201605 20160526 0
124305453 12430545 2 201605 20160526 0
124305453 12430545 3 20160526 0
124305453 12430545 4 20160526 0
124305453 12430545 5 20160520 0
124305453 12430545 6 20160520 0
124305453 12430545 10 20160520 0
124305453 12430545 11 20160520 0